Takeda Pharmaceutical Co. Ltd. - Ebit Interest Coverage

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Ebit-Interest-Coverage" stands at 1.37 as of 09/30/2025, the lowest value since 09/30/2024.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Ebit Interest Coverage" stands at 1.37. This represents a decrease of -21.58 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -34.57 percent compared to the value the year prior.
The 1 year change in percent is -34.57.
The 3 year change in percent is -42.94.

The Serie's long term average value is 2.02. It's latest available value, on 09/30/2025, is 32.16 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +14.35%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -50.32%.